resveratrol has been researched along with 3-methylcholanthrene in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (80.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baer-Dubowska, W; Balana, B; Ignatowicz, E; Szaefer, H; Vulimiri, SV | 1 |
Hagiwara, H; Ishihara, Y; Miyagawa-Tomita, S; Naruse, M; Otsuka, E | 1 |
Ho, PY; Juan, SH; Lee, JL; Lee, WS; Lee, YH | 1 |
Hou, HH; Hsu, SP; Juan, SH; Lee, YH; Lin, YH; Pang, PH | 1 |
Dvorak, Z; Novotna, A; Pavek, P | 1 |
5 other study(ies) available for resveratrol and 3-methylcholanthrene
Article | Year |
---|---|
The effect of plant phenolics on the formation of 7,12-dimethylbenz[a]anthracene-DNA adducts and TPA-stimulated polymorphonuclear neutrophils chemiluminescence in vitro.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Chlorogenic Acid; DNA; DNA Adducts; Enzyme Inhibitors; Humans; Hydrolyzable Tannins; Hydroxybenzoates; Luminescent Measurements; Male; Methylcholanthrene; Neutrophils; Phenols; Rats; Rats, Wistar; Reactive Oxygen Species; Respiratory Burst; Resveratrol; Stilbenes; Tetradecanoylphorbol Acetate | 2003 |
Inhibition of osteoclast formation by 3-methylcholanthrene, a ligand for arylhydrocarbon receptor: suppression of osteoclast differentiation factor in osteogenic cells.
Topics: Animals; Carcinogens; Carrier Proteins; Drug Interactions; Male; Membrane Glycoproteins; Methylcholanthrene; Mice; Osteoclasts; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Receptors, Aryl Hydrocarbon; Resveratrol; Stilbenes | 2004 |
Antiproliferative and antiangiogenic effects of 3-methylcholanthrene, an aryl-hydrocarbon receptor agonist, in human umbilical vascular endothelial cells.
Topics: Angiogenesis Inhibitors; Animals; Blotting, Western; Capillaries; Cattle; Cell Adhesion; Cell Movement; Cell Proliferation; Cells, Cultured; Cytochrome P-450 CYP1A1; DNA Replication; Dose-Response Relationship, Drug; Down-Regulation; Endothelium, Vascular; Flow Cytometry; Focal Adhesion Protein-Tyrosine Kinases; G1 Phase; Growth Inhibitors; Humans; Methylcholanthrene; Phosphorylation; Receptors, Aryl Hydrocarbon; Resting Phase, Cell Cycle; Resveratrol; Serum Albumin, Bovine; Signal Transduction; Stilbenes; Thymidine; Time Factors; Tritium; Tumor Necrosis Factor-alpha; Umbilical Veins; Up-Regulation | 2006 |
Molecular mechanisms of p21 and p27 induction by 3-methylcholanthrene, an aryl-hydrocarbon receptor agonist, involved in antiproliferation of human umbilical vascular endothelial cells.
Topics: Cell Cycle; Cell Proliferation; Cells, Cultured; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Dose-Response Relationship, Drug; Endothelial Cells; Enzyme Activation; Gene Expression Regulation; Humans; Luciferases; Methylcholanthrene; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Binding; Receptors, Aryl Hydrocarbon; Response Elements; Resveratrol; Sequence Deletion; Stilbenes; Time Factors; Tritium; Umbilical Cord | 2008 |
Novel stably transfected gene reporter human hepatoma cell line for assessment of aryl hydrocarbon receptor transcriptional activity: construction and characterization.
Topics: Anthracenes; Gene Expression; Hep G2 Cells; Humans; Indoles; Luciferases; Methylcholanthrene; Omeprazole; Polychlorinated Dibenzodioxins; Receptors, Aryl Hydrocarbon; Resveratrol; Signal Transduction; Stilbenes; Transfection | 2011 |